%0 Journal Article
%T Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?
%A Karachaliou, Niki
%A Fernandez-Bruno, Manuel
%A Rosell, Rafael
%J Translational Lung Cancer Research
%D 2018
%B 2018
%9 
%! Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?
%K 
%X The initial treatment for metastatic squamous cell non-small cell lung cancer (NSCLC) consists of platinum-based combination chemotherapy. The most commonly used regimens are carboplatin and paclitaxel, carboplatin and protein-bound paclitaxel (nab-paclitaxel), and cisplatin and gemcitabine.
%U https://tlcr.amegroups.org/article/view/22760
%P S198-S201
%@ 2226-4477